IL6 and lung carcinoma: Lung cancer patients have elevated levels of interleukin-6 (IL-6), which can upregulate hepcidin (29) (a systemic iron availability regulator – for more information on iron homeostasis regulation, refer to our review titled “ Iron and Organismal Aging” (1)).